The NRC Doesn't Cut Corners on Safety

The excerpts from the book Safety Second by the Union of Concerned Scientists about the activities of the Nuclear Regulatory Commission that appeared in the June 15, 1987 issue of The Scientist (p. 15) deserve comment. At the outset, it should be noted that the Union of Concerned Scientists is hardly an unbiased observer of the NRC. Since its formation, the organization has been critical of our agency and how we carry out our responsibilities. Nevertheless, we welcome constructive criticism and

Written byHarold Denton
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

At the outset, it should be noted that the Union of Concerned Scientists is hardly an unbiased observer of the NRC. Since its formation, the organization has been critical of our agency and how we carry out our responsibilities. Nevertheless, we welcome constructive criticism and we go to great lengths to consider all comments as we seek to improve not only how we carry out our mission, but also our efforts to improve the safety of U.S. nuclear power plants.

Protection of the public and of the people who work in these plants is the principal goal in all our activities. Contrary to the statement of the UCS, our allegiance is not to the industry we regulate. It is to the public we serve. The more than 3,000 people who work for the NRC are dedicated public servants who take their important responsibilities most seriously. We tackle safety problems vigorously ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies